Abstract
This study highlights the need for further exploration of factors that influence the declining incidence rate of Stevens–Johnson syndrome/toxic epidermal necrolysis (SJS/TEN), interventions to mitigate loss-of-life expectancy and healthcare costs, and impact on quality of life. The findings emphasize the importance of ongoing efforts to minimize the burden of SJS/TEN and optimize patient care.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
